Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil Infusion Time to Prevent Cough During Anesthesia Induction
NCT07778953Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial of sufentanil in cough. Primary endpoint: 90% effective infusion time of sufentanil for preventing sufentanil-induced cough. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
sufentanil
03
Conditions
cough
Beyond the preview
Go deeper on NCT07778953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07778953.